ENCINO, CALIF., May 19, 2016 — Research Solutions, Inc. (OTCQB: RSSS) announced today the engagement of private acquisition advisory firm Harvey & Company, LLC to help the company identify potential acquisitions. Research Solutions is a publicly traded holding company that is a pioneer in providing on-demand access to scientific, technical, and medical (STM) information for life science companies, academic institutions and other research-intensive organizations, including more than 70 percent of the world’s top 25 pharmaceutical companies.
“Research Solutions has healthy levels of organic growth today with extremely high customer retention rates and recurring revenues,” said Peter Derycz, President and CEO of Research Solutions. “As part of our efforts to increase shareholder value, Research Solutions is pursuing all options to fuel growth including possible acquisitions that improve net present value.”
On a very select basis, Harvey & Company works with acquisitive companies to identify and evaluate opportunities for growth, including public companies, private equity-backed portfolio companies, private companies, foreign-owned companies, and private equity investors seeking new investments.
About Harvey & Company
Harvey & Company is a leading buy-side acquisition advisory firm working on behalf of acquisitive corporations and private equity firms. Harvey & Company's principals have initiated 200+ acquisitions, including over 60 in the past four years, all as the advisor to the buyer. Acquirers choose to partner with Harvey & Company due to our experienced professionals and proven processes that consistently generate strategic deal flow. For more information about Harvey & Company, visit www.harveyllc.com.
About Research Solutions
Operating through its wholly owned subsidiary, Reprints Desk®, Inc., Research Solutions, Inc. (OTCQB: RSSS) is a pioneer in providing on-demand access to scientific, technical, and medical (STM) information for life science companies, academic institutions and other research intensive organizations. More than 70 percent of the top 25 pharmaceutical companies in the world rely on services powered by Research Solutions. Article Galaxy™, the company’s cloud-based software-as-a-service (SaaS) solution, gives customers access to the over one million newly published articles each year in addition to tens of millions of articles previously published, helping them to create and speed discoveries, save time and money, and remain copyright-compliant. Research Solutions has arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, the company also serves STM publishers by facilitating compliance with applicable copyright laws. For more information about Research Solutions, visit www.researchsolutions.com.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008. For more information about Reprints Desk, visit www.reprintsdesk.com.
Important Cautions Regarding Forward-Looking Statements
This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. Examples of such forward-looking statements in this release include statements regarding the Company's success in integrating acquired assets and the expected continued market acceptance of the Article Galaxy platform. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source: Research Solutions
Chief Sales and Marketing Officer
Reprints Desk, Inc.
5435 Balboa Blvd., Suite 202
Encino, CA 91316
+1 (415) 533-8308